(Q48664197)

14 February 2018

title

U-95666E: a potential anti-parkinsonian drug with anxiolytic activity. (English)

1 reference

14 February 2018

1 reference

Sethy VH

1

1 reference

14 February 2018

Ellerbrock BR

series ordinal

2

1 reference

14 February 2018

Wu H

series ordinal

3

1 reference

14 February 2018

publication date

1 July 1997

1 reference

14 February 2018

Progress in Neuro-Psychopharmacology & Biological Psychiatry

published in

1 reference

14 February 2018

volume

21

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

873-883

1 reference

14 February 2018

Biochemistry of Parkinson's disease 28 years later: a critical review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Acetylcholine measurement by high-performance liquid chromatography using an enzyme-loaded postcolumn reactor.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

The rationale for the use of dopamine agonists in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

D2 dopamine receptor mRNA distribution in cholinergic and somatostatinergic cells of the rat caudate-putamen and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Parkinson's disease and anxiety: comorbidity with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

ZK 91296, a partial agonist at benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Role of cGMP in the mechanism of anxiolytic activity of U-78875

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Regulation of striatal acetylcholine concentration by dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Anxiety and motor performance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Anxiety disorders in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Dopamine agonists in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

LY141865, a D2-dopamine agonist, increases acetylcholine concentration in rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2897%2900086-9

7 January 2021

10.1016/S0278-5846(97)00086-9

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018